IART Integra Lifesciences
- 28.340
- -0.070-0.25%
- 28.340
- 0.0000.00%
Integra Lifesciences News
Buy Rating for Integra Lifesciences Amid Favorable Medicare Policy Changes
Jefferies Sticks to Their Buy Rating for Integra Lifesciences (IART)
Integra Lifesciences Analyst Ratings
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target Is $38
Integra Lifesciences Analyst Ratings
BTIG Sticks to Its Hold Rating for Integra Lifesciences (IART)
Buy Rating on Integra Lifesciences Amidst Recovery and Growth Prospects
Integra Lifesciences: Sell Rating Justified by Underwhelming Financials and Leadership Concerns
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Integra Lifesciences (IART)
Analysts Are Bullish on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Integra Lifesciences (IART)
Integra Lifesciences (IART) Receives Buy Rating Following FDA Approval of CereLink Monitors
Analysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)
Integra Lifesciences Analyst Ratings
Integra Lifesciences Analyst Ratings
Wells Fargo Upgrades Integra Lifesciences to Overweight, Raises Price Target to $49
Integra Lifesciences Analyst Ratings
Integra Lifesciences Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Integra Lifesciences (IART) and Revvity (RVTY)
Integra Lifesciences Analyst Ratings
Integra Lifesciences' Underperformance and Recall Issues Prompt Sell Rating: An Analysis by Joanne Wuensch
Analysis
Price Target
No Data
